NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/22/2024
Back to search
Official data from USPTO
INTEVAGENCE THE EXPERT FORUM FOR ADVANCING ONCOLOGY CARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
11/22/2024
Trademark type
Combined
Nice classes
38
Filing date
04/19/2013
Registration date
09/09/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/22/2024
Last transaction
11/22/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/28/2014
First use in commerce
02/28/2014
Drawing code
3
Owner type
99
Owner location
Tel Aviv, IL
Examiner
FIORELLI, JOANNA
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "INTEVAGENCE" written at the center of the logo with the stylized slogan "THE EXPERT FORUM FOR ADVANCING ONCOLOGY CARE" at the bottom. There is also a design of a magnifying glass above the slogan. Within the circle of the magnifying glass appear two shaded rectangles and two shaded triangles with curved sides. Two shaded triangles with curved sides appear outside of the magnifying glass.
Holders and representatives
Holders
TEVA Pharmaceutical Industries Limited
TEVA Pharmaceutical Industries Limited
Representatives
Laurence Rickles TEVA PHARMACEUTICALS USA, Inc.
Technical classification
Nice Classes
Class 38
Vienna Codes
No Vienna codes available.
Goods and services
Class 38
Providing on-line educational forums for health care professionals in the field of cancer treatment
Publications
History of USPTO decisions and trademark events.
52 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/22/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/22/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/22/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
08/21/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/09/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/22/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/22/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/22/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/22/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/22/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/02/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/02/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/01/2020
E815
TEAS SECTION 8 & 15 RECEIVED
08/10/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/09/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/01/2015
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/01/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
09/09/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/08/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/07/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/21/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/21/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/21/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/23/2014
GNRT
NON-FINAL ACTION E-MAILED
06/23/2014
CNRT
SU - NON-FINAL ACTION - WRITTEN
06/23/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/12/2014
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/10/2014
IUAF
USE AMENDMENT FILED
05/20/2014
EISU
TEAS STATEMENT OF USE RECEIVED
05/20/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/10/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2013
PUBO
PUBLISHED FOR OPPOSITION
10/15/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/12/2013
ALIE
ASSIGNED TO LIE
09/11/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/30/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
08/29/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/29/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
08/29/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/29/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/20/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/19/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/19/2013
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
07/29/2013
GPRA
PRIORITY ACTION E-MAILED
07/29/2013
CPRA
PRIORITY ACTION WRITTEN
07/29/2013
DOCK
ASSIGNED TO EXAMINER
07/16/2013
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/27/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/26/2013
NWAP
NEW APPLICATION ENTERED
04/23/2013
Continuous trademark protection
Get notified about every new filing that threatens INTEVAGENCE THE EXPERT FORUM FOR ADVANCING ONCOLOGY CARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.